U.S. Department of Health and Human Services
Kristina Rother

 Contact Info

Tel: 301-435-4639
Email: kristinar@intra.niddk.nih.gov

 Select Experience

  • Clinical InvestigatorNIDDK, NIH2000-present
  • Senior FellowNIDDK, NIH1998-2000
  • Visiting AssociatePediatric Endocrinology, NICHD, NIH1995-1998
  • Visiting ScientistInstitute of Molecular Biology II, University of Zurich, Switzerland1994-1995
  • Fellowship in Pediatric EndocrinologyMassachusetts General Hospital and Mayo Clinic1991-1994
  • Residency in Pediatrics (years 2 and 3)Mayo Clinic1989-1991
  • Internship in Pediatric EndocrinologyChildren’s Hospital Zurich1988-1989
  • Residency in Pediatrics (year 1)Mayo Clinic1987-1988
  • M.H.Sc.NIH and Duke University2008
  • M.D. & Doctoral ThesisAlbert Ludwigs University Freiburg1986

 Related Links


Kristina Ingeborg Rother, M.D.

Senior Research Physician, Section on Pediatric Diabetes and MetabolismDiabetes, Endocrinology, and Obesity Branch
  • Clinical Research


A selection of recent and significant publications can be viewed below.

Cizza G, de Jonge L, Piaggi P, Mattingly M, Zhao X, Lucassen E, Rother KI, Sumner AE, Csako G. Neck Circumference Is a Predictor of Metabolic Syndrome and Obstructive Sleep Apnea in Short-Sleeping Obese Men and Women. Metab Syndr Relat Disord. 2014 May; 12 (2014 May; 4; 12):231-41. [Full Text/Abstract]
Nguyen TT, Jayadeva V, Cizza G, Brown RJ, Nandagopal R, Rodriguez LM, Rother KI. Challenging Recruitment of Youth With Type 2 Diabetes Into Clinical Trials. J Adolesc Health. 2014 Mar; 54 (2014 Mar; 3; 54):247-254. [Full Text/Abstract]
Sarkar G, Alattar M, Brown RJ, Quon MJ, Harlan DM, Rother KI. Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes. Diabetes Care. 2014 Mar; 37 (2014 Mar; 37; 3):666-70. [Full Text/Abstract]
Schiffman SS, Rother KI. Sucralose, a synthetic organochlorine sweetener: overview of biological issues. J Toxicol Environ Health B Crit Rev. 2013; 16 (16; 7; 2013):399-451. [Full Text/Abstract]
Brown RJ, Rother KI. Non-nutritive sweeteners and their role in the gastrointestinal tract. J Clin Endocrinol Metab. 2012 Aug; 97 (2012 Aug; 8; 97):2597-605. [Full Text/Abstract]
Brown RJ, Walter M, Rother KI. Effects of diet soda on gut hormones in youths with diabetes. Diabetes Care. 2012 May; 35 (2012 May; 35; 5):959-64. [Full Text/Abstract]
Cizza G, Brown RJ, Rother KI. Rising incidence and challenges of childhood diabetes. A mini review. J Endocrinol Invest. 2012 May; 35 (2012 May; 35; 5):541-6. [Full Text/Abstract]
Cizza G, Rother KI. Beyond fast food and slow motion: weighty contributors to the obesity epidemic. J Endocrinol Invest. 2012 Feb; 35 (2012 Feb; 35; 2):236-42. [Full Text/Abstract]
Sylvetsky A, Rother KI, Brown R. Artificial sweetener use among children: epidemiology, recommendations, metabolic outcomes, and future directions. Pediatr Clin North Am. 2011 Dec; 58 (6; 58; 2011 Dec):1467-80, xi. [Full Text/Abstract]
Cizza G, Rother KI. Was Feuerbach right: are we what we eat?. J Clin Invest. 2011 Aug; 121 (8; 121; 2011 Aug):2969-71. [Full Text/Abstract]
Brown RJ, Wijewickrama RC, Harlan DM, Rother KI. Uncoupling intensive insulin therapy from weight gain and hypoglycemia in type 1 diabetes. Diabetes Technol Ther. 2011 Apr; 13 (2011 Apr; 4; 13):457-60. [Full Text/Abstract]
Gemmill JA, Brown RJ, Nandagopal R, Rodriguez LM, Rother KI. Clinical trials in youth with type 2 diabetes. Pediatr Diabetes. 2011 Feb; 12 (2011 Feb; 12; 1):50-7. [Full Text/Abstract]
Brown RJ, de Banate MA, Rother KI. Artificial sweeteners: a systematic review of metabolic effects in youth. Int J Pediatr Obes. 2010 Aug; 5 (4; 2010 Aug; 5):305-12. [Full Text/Abstract]
Nandagopal R, Brown RJ, Rother KI. Resolution of type 2 diabetes following bariatric surgery: implications for adults and adolescents. Diabetes Technol Ther. 2010 Aug; 12 (8; 12; 2010 Aug):671-7. [Full Text/Abstract]
Laferrère B, Swerdlow N, Bawa B, Arias S, Bose M, Oliván B, Teixeira J, McGinty J, Rother KI. Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes. J Clin Endocrinol Metab. 2010 Aug; 95 (95; 8; 2010 Aug):4072-6. [Full Text/Abstract]
Rother KI, Spain LM, Wesley RA, Digon BJ 3rd, Baron A, Chen K, Nelson P, Dosch HM, Palmer JP, Brooks-Worrell B, Ring M, Harlan DM. Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes. Diabetes Care. 2009 Dec; 32 (32; 12; 2009 Dec):2251-7. [Full Text/Abstract]
Brown RJ, Walter M, Rother KI. Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion. Diabetes Care. 2009 Dec; 32 (32; 12; 2009 Dec):2184-6. [Full Text/Abstract]